ANAGRAM THERAPEUTICS
LIVE

Serial Number

97913497

Owner

Anagram Therapeutics, Inc.

Attorney

Jessica L. Rothstein

Filing Date

Apr 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ANAGRAM THERAPEUTICS Trademark

Serial Number: 97913497 • Registration: 8196638

ANAGRAM THERAPEUTICS is a trademark filed by Anagram Therapeutics, Inc. on April 28, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Anagram Therapeutics, Inc.

33 Strathmore Road
Natick, MA 01760

Entity Type: 03

Trademark Details

Filing Date

April 28, 2023

Registration Date

March 31, 2026

Published for Opposition

March 12, 2024

Goods & Services

Pharmaceutical preparations for the treatment of malabsorption syndromes, nutrient metabolism disorders, rare diseases, congenital disorders, pancreatic diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders and inflammatory diseases and disorders

Research and development in the field of oral enzyme therapies; pharmaceutical research and development services; providing scientific research information in the field of pharmaceuticals, oral enzyme therapies, and clinical trials; research and development of pharmaceuticals and therapeutics for the treatment of malabsorption syndromes, nutrient metabolism disorders, rare diseases, congenital disorders, pancreatic diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders and inflammatory diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 31, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 12, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 12, 2026 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 12, 2026 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Mar 11, 2026 SUPC
SOU EXTENSION 3 GRANTED
Mar 11, 2026 EX3G
USE AMENDMENT FILED
Oct 17, 2025 IUAF
SOU EXTENSION 3 FILED
Oct 17, 2025 EXT3
TEAS STATEMENT OF USE RECEIVED
Oct 17, 2025 EISU
SOU TEAS EXTENSION RECEIVED
Oct 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
May 3, 2025 EX2G
SOU EXTENSION 2 FILED
May 3, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
May 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 5, 2024 EXRA
SOU EXTENSION 1 GRANTED
Nov 5, 2024 EX1G
SOU EXTENSION 1 FILED
Nov 5, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 5, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 7, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 30, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 30, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 30, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 30, 2024 CNEA
ASSIGNED TO EXAMINER
Jan 25, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2023 NWOS
NEW APPLICATION ENTERED
May 2, 2023 NWAP